Department of Neurosurgery, Gaozhou People's Hospital, Gaozhou, Guangdong, China.
Department of Radiation Oncology, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou, Guangdong, China.
Cancer Med. 2020 Sep;9(17):6387-6398. doi: 10.1002/cam4.3186. Epub 2020 Jul 20.
Mounting literatures have revealed the crucial effects of long noncoding RNA (lncRNA) in various cancers, including glioma. HNF1A-AS1, a novel lncRNA, is reported to modulate tumorigenesis and development of multiple cancers. However, the tumorigenic function of lncRNA HNF1A-AS1 in glioma remains largely unknown. quantitative reverse transcription and polymerase chain reaction and western blot assays were applied to evaluate the expression of relevant mRNAs and proteins. 5-Ethynyl-2'- deoxyuridine, terminal deoxynucleotidyl transferase dUTP nick-end labeling, flow cytometry, and transwell assays were conducted for examining the influence of HNF1A-AS1 on glioma cell functions. The relationship among RNAs was investigated by mechanical experiments. The results demonstrated that HNF1A-AS1 was predominantly highly expressed in glioma cell lines compared with nontumor glial epithelial cell, which was associated with the stimulation of transcription factor myelocytomatosis oncogene. Knockdown of HNF1A-AS1 remarkably inhibited glioma cells proliferation, migration, and invasion, while accelerating cell apoptosis in vitro. Mechanically, HNF1A-AS1 served as a miR-32-5p sponge. Moreover, SOX4 was discovered as a target of miR-32-5p. Inhibited miR-32-5p or upregulated SOX4 could markedly counteract the inhibitory effects of silencing HNF1A-AS1 on glioma malignant biological behaviors. HNF1A-AS1 exerted oncogenic property in glioma progression via upregulating miR-32-5p-mediated SOX4 expression, suggesting potential novel therapeutic target for future glioma treatment.
越来越多的文献表明长链非编码 RNA(lncRNA)在包括神经胶质瘤在内的各种癌症中具有重要作用。HNF1A-AS1 是一种新型 lncRNA,据报道可调节多种癌症的肿瘤发生和发展。然而,lncRNA HNF1A-AS1 在神经胶质瘤中的致瘤功能仍知之甚少。应用定量逆转录聚合酶链反应和 Western blot 检测相关 mRNA 和蛋白的表达。5-乙炔基-2'-脱氧尿苷、末端脱氧核苷酸转移酶 dUTP 缺口末端标记、流式细胞术和 Transwell 检测用于研究 HNF1A-AS1 对神经胶质瘤细胞功能的影响。通过力学实验研究 RNA 之间的关系。结果表明,与非肿瘤神经胶质上皮细胞相比,HNF1A-AS1 在神经胶质瘤细胞系中表达明显升高,这与转录因子髓细胞瘤癌基因的刺激有关。HNF1A-AS1 敲低显著抑制神经胶质瘤细胞的增殖、迁移和侵袭,同时促进体外细胞凋亡。在机制上,HNF1A-AS1 作为 miR-32-5p 的海绵。此外,发现 SOX4 是 miR-32-5p 的靶标。抑制 miR-32-5p 或上调 SOX4 可以显著抵消沉默 HNF1A-AS1 对神经胶质瘤恶性生物学行为的抑制作用。HNF1A-AS1 通过上调 miR-32-5p 介导的 SOX4 表达发挥致癌作用,提示未来神经胶质瘤治疗的潜在新治疗靶点。